Summary of Facts and SubmissionsI. European patent No. 0 500 917 with the title Recombinant herpes simplex viruses vaccines and methods" was granted based on European application No. 91918320.2 with claims 1 to 13 for all designated Contracting States except ES and GR, claims 1 to 8 for the Contracting State ES and claims 1 to 13 for the Contracting State GR.II. Claim 37 to 39, 43 and 44 of the a